Generic Portal

— Research Explorer

Canagliflozin inhibits inflammasome activation in diabetic endothelial cells – Revealing a novel calcium-dependent anti-inflammatory effect of canagliflozin on human diabetic endothelial cells

Research output: Contribution to journal › Article › Academic › peer-review

DOI

https://doi.org/10.1016/j.biopha.2023.114228
Final published version

Original language	English
Article number	114228
Journal	Biomedicine and Pharmacotherapy
Volume	159
DOIs	https://doi.org/10.1016/j.biopha.2023.114228
Publication status	Published - 1 Mar 2023

Research areas

Canagliflozin (CANA), Extracellular signal regulated kinase (ERK) 1/2 phosphorylation, Interleukin (IL)− 1β, Intracellular calcium (Ca ), Nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome, Reactive oxygen species (ROS)

ID: 30840129